文献速递肝病

肠道菌群介导小鼠对乙酰氨基酚诱导急性肝损伤的昼夜节律变化

Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice.
PubMed 文献 · J Hepatol · 2018-03-08

研究以雄性Balb/C小鼠为对象,在ZT0与ZT12给予口服对乙酰氨基酚300 mg/kg,发现ZT12肝损伤较ZT0明显加重,抗生素处理或给予ZT0盲肠内容物可减轻该差异,肠道菌群代谢物1-苯基-1,2-丙二酮(PPD)在ZT12升高并协同增强肝损伤,酿酒酵母可降低肠道PPD水平并明显减轻ZT12肝损伤。

要点

  • 对乙酰氨基酚肝损伤在ZT12较ZT0明显加重。
  • 抗生素处理或移植ZT0盲肠内容物可减轻ZT12肝损伤。
  • 肠道菌群代谢物PPD在ZT12升高并协同增强对乙酰氨基酚肝损伤。

核心结论

  • 肠道菌群代谢物PPD至少部分通过降低谷胱甘肽水平参与对乙酰氨基酚诱导肝毒性的昼夜节律变化。

研究设计与样本

  • 雄性Balb/C小鼠接受或不接受抗生素处理,并在ZT0与ZT12单次口服对乙酰氨基酚300 mg/kg。

主要发现

  • 肝损伤在ZT12较ZT0明显加重。
  • 抗生素处理后,ZT12对乙酰氨基酚肝毒性呈现与ZT0相似的保护作用。
  • 接受ZT12盲肠内容物的小鼠较接受ZT0盲肠内容物的小鼠肝损伤更严重。
  • 16S测序显示ZT0与ZT12盲肠内容物在组成水平存在显著差异。
  • 代谢组学分析显示ZT0与ZT12肠道菌群代谢物不同,PPD水平在ZT12显著高于ZT0。

关键数值与推荐

  • 单用PPD未引起明显肝损伤。
  • PPD在体内和体外协同增强对乙酰氨基酚诱导的肝损伤。
  • 酿酒酵母可降低肠道PPD水平,并在ZT12明显减轻对乙酰氨基酚诱导的肝损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acetaminophen (APAP) induced hepatotoxicity is a leading cause of acute liver failure worldwide. It is well established that the liver damage induced by acetaminophen exhibits diurnal variation. However, the detailed mechanism for the hepatotoxic variation is not clear. Herein, we aimed to determine the relative contributions of gut microbiota in modulating the diurnal variation of hepatotoxicity induced by APAP. METHODS: Male Balb/C mice were treated with or without antibiotics and a single dose of orally administered APAP (300 mg/kg) at ZT0 (when the light is on-start of resting period) and ZT12 (when the light is off-start of active period). RESULTS: In agreement with previous findings, hepatic injury was markedly enhanced at ZT12 compared with ZT0. Interestingly, upon antibiotic treatment, ZT12 displayed a protective effect against APAP hepatotoxicity similar to ZT0. Moreover, mice that received the cecal content from ZT12 showed more severe liver damage than mice that received the cecal content from ZT0. 16S sequencing data revealed significant differences in the cecal content between ZT0 and ZT12 in the compositional level. Furthermore, metabolomic analysis showed that the gut microbial metabolites were also different between ZT0 and ZT12. Specifically, the level of 1-phenyl-1,2-propanedione (PPD) was significantly higher at ZT12 than ZT0. Treatment with PPD alone did not cause obvious liver damage. However, PPD synergistically enhanced APAP-induced hepatic injury in vivo and in vitro. Finally, we found Saccharomyces cerevisiae, which could reduce intestinal PPD levels, was able to markedly alleviate APAP-induced liver damage at ZT12. CONCLUSIONS: The gut microbial metabolite PPD was responsible, at least in part, for the diurnal variation of hepatotoxicity induced by APAP by decreasing glutathione levels. LAY SUMMARY: Acetaminophen (APAP) induced acute liver failure because of over dose is a leading public health problem. APAP-induced liver injury exhibits diurnal variation, specifically APAP causes more severe liver damage when taken at night compared with in the morning. Herein, we showed that gut microbial metabolite, 1-phenyl-1,2-propanedione is involved in the rhythmic hepatotoxicity induced by APAP, by depleting hepatic glutathione (an important antioxidant) levels. Our data suggest gut microbiota may be a potential target for reducing APAP-induced acute liver injury.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Gong S, Lan T, Zeng L, et al. Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice. J Hepatol. 2018. PMID: 29524531. doi:10.1016/j.jhep.2018.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。